See the DrugPatentWatch profile for human
What portion of FDA’s human drug review budget comes from PDUFA funding?
The provided information doesn’t include any figures tying PDUFA (Prescription Drug User Fee Act) funding to a specific percentage of the FDA’s human drug review budget. Without a source that states that proportion, I can’t give an accurate funding percentage.
Where can you find the exact PDUFA share of the human drug review budget?
To get the exact percentage, you typically need FDA budget documents that break out:
- the total amount spent (or planned) for human drug review, and
- how much of that total is supported by PDUFA user fees (vs. other appropriations).
If you share the document name or link you’re looking at (or the fiscal year), I can help you calculate the percentage from the line items.
Why the percentage can vary by fiscal year (and what to check)
Even when a percentage is published, it often changes depending on:
- the fiscal year (FDA budgets change year to year),
- whether you’re comparing “user fee-funded” activities versus “total human drug review” spending, and
- whether the scope includes only CDER review or also broader drug-related FDA activities.
If you want, I can calculate it—what fiscal year and budget document?
Tell me:
1) the fiscal year (e.g., FY2024 or FY2025), and
2) the source document you’re using (FDA budget justification, performance report, etc.),
and I’ll compute the PDUFA funding percentage against the human drug review budget using the numbers in that document.
Sources: None provided in the prompt.